Zim Laboratories Ltd Performance
Day's Low
Day's High
₹103.25Day's Price Range₹105.9452 Week's Low
52 Week's High
₹89.552-Week Price Range₹131.4
| Returns % | |
| 1 Month Return | -3.21 % |
| 3 Month Return | -3.83 % |
| 1 Year Return | -2.76 % |
| Market Stats | |
| Previous Close | ₹105.60 |
| Open | ₹105.94 |
| Volume | 19.29K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹514.54Cr |
Zim Laboratories Ltd Key Statistics
| P/E Ratio | 31.9 |
| PEG Ratio | -75.96 |
| Market Cap | ₹514.54 Cr |
| P/B Ratio | 2.01 |
| EPS | 3.54 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 7.87 |
Zim Laboratories Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹514.54 Cr | 10.17% | 0.66 | ₹17 Cr | ₹367 Cr | |
| BUY | ₹14,495.06 Cr | 65.42% | 0.63 | ₹405 Cr | ₹4,506 Cr | |
| NA | ₹890.07 Cr | 539.74% | 0.65 | ₹23 Cr | ₹307 Cr | |
| NA | ₹493.21 Cr | 18.44% | 0.00 | NA | NA | |
| NA | ₹15,135.40 Cr | -0.97% | 0.73 | ₹82 Cr | ₹1,465 Cr |
About Zim Laboratories Ltd
Share Price: ₹103.74 per share as on 21 Jan, 2025 04:01 PM
Market Capitalisation: ₹514.54Cr as of today
Revenue: ₹92.14Cr as on September 2024 (Q3 24)
Net Profit: ₹2.38Cr as on September 2024 (Q3 24)
Listing date: 25 Nov, 2022
Chairperson Name: Anwar S Daud
| Organisation | Zim Laboratories Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Zim Laboratories Ltd
ZIM Laboratories Receives European Marketing Authorization - 10 Jan, 2025
ZIM Laboratories, in partnership with Neuraxpharm Group, has received Marketing Authorization for Buprenorphine Sublingual Film in Europe, enhancing opioid dependency treatment. This innovative product aims to improve patient compliance and safety.
Insights on Zim Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 0.9 Cr → 2.38 Cr (in ₹), with an average increase of 62.2% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 82.82 Cr → 93.46 Cr (in ₹), with an average increase of 11.4% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.00% to 0.21% in Dec 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 46.6% return, outperforming this stock by 61.1%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 33.26% of holdings in Dec 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 103.2% return, outperforming this stock by 140.9%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 66.63% to 66.28% in Dec 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 years, ZIMLAB stock has moved down by -37.7%
Zim Laboratories Ltd Financials
Zim Laboratories Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 33.26% | 0.00 | |
| Foreign Institutions | 0.21% | 5267.50 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 66.28% | ||
| Others | 0.24% | 131.35 |
Zim Laboratories Ltd Key Indicators
Zim Laboratories Ltd Valuation
Zim Laboratories Ltd in the last 5 years
Lowest (6.12x)
June 11, 2018
Today (31.90x)
January 20, 2025
Industry (55.28x)
January 20, 2025
Highest (198.80x)
July 1, 2021
Zim Laboratories Ltd Earnings and Dividends
Zim Laboratories Ltd Earnings Results
Zim Laboratories Ltd’s net profit fell -42.65% since last year same period to ₹2.38Cr in the Q2 2024-2025. On a quarterly growth basis, Zim Laboratories Ltd has generated 164.44% jump in its net profits since last 3-months.
Read More about Earnings ResultsZim Laboratories Ltd Dividends May,2019
In the quarter ending March 2019, Zim Laboratories Ltd has declared dividend of ₹0.50 - translating a dividend yield of 1.42%.
Read More about Dividends
Zim Laboratories Ltd Technicals Summary
Bearish
Neutral
Bullish
Zim Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Zim Laboratories Ltd
Zim Laboratories Ltd share price today stands at ₹103.74, Open. ₹105.94 ; Previous Close. ₹105.6 ; High. ₹105.94 ; Low. ₹103.25 ; 52 Week High. ₹131.4 ; 52 Week Low: ₹89.5.
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Zim Laboratories Ltd shares.
Zim Laboratories Ltd is listed on NSE
Zim Laboratories Ltd is listed on BSE
- Today’s highest price of Zim Laboratories Ltd is ₹105.94.
- Today’s lowest price of Zim Laboratories Ltd is ₹103.25.
PE Ratio of Zim Laboratories Ltd is 31.9
PE ratio = Zim Laboratories Ltd Market price per share / Zim Laboratories Ltd Earnings per share
Today’s traded volume of Zim Laboratories Ltd(ZIMLAB) is 19.29K.
Today’s market capitalisation of Zim Laboratories Ltd(ZIMLAB) is ₹514.54Cr.
| Zim Laboratories Ltd(ZIMLAB | Price |
|---|---|
52 Week High | ₹131.4 |
52 Week Low | ₹89.5 |
Zim Laboratories Ltd(ZIMLAB) share price is ₹103.74. It is down -21.05% from its 52 Week High price of ₹131.4
Zim Laboratories Ltd(ZIMLAB) share price is ₹103.74. It is up 15.91% from its 52 Week Low price of ₹89.5
| Zim Laboratories Ltd(ZIMLAB | Returns |
|---|---|
1 Day Returns | -1.86% |
1 Month Returns | -3.21% |
3 Month Returns | -3.83% |
1 Year Returns | -2.76% |